Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big Pharma CEOs
Emma Walmsley’s £1 million ($1.3 million) pay raise in 2018 might have made her the highest-paid women on the FTSE 100, but the GlaxoSmithKline CEO’s compensation package still trails her peers in Big Pharma corner offices.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.